Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

MediLedger Project Gearing Up for Saleable Returns: Part I

Q&A with a supply chain expert from AmerisourceBergen zeroes in on track-and-trace regulations and how blockchain is helping the MediLedger working group.

Heather Zenk, Vice President, Global Secure Supply Chain Operations at AmerisourceBergen
Heather Zenk, Vice President, Global Secure Supply Chain Operations at AmerisourceBergen

The pharmaceutical industry is abuzz with concern over how to best meet the traceability requirements spelled out in the Drug Supply Chain Security Act (DSCSA).

Per the DSCSA, by Nov. 27, 2019 wholesale distributors will have to verify serialized product identifiers of saleable returned packages or sealed homogenous cases of product that are intended for further distribution (section 582(c)(4)(D)).

In 2018, a group of companies launched the MediLedger Project, which brings together major pharmaceutical manufacturers and distributors to create a collaborative network.

Heather Zenk, Vice President, Global Secure Supply Chain Operations at AmerisourceBergen, is a knowledgeable member of the working group. “Using blockchain, the project creates evolving solutions for track-and-trace regulations, and provides a step-function improvement in the overall operation of the supply chain,” she explains.

Here Zenk discusses the initiative, testing and the role of blockchain.

Q: What is AmerisourceBergen’s role in the MediLedger Project?

A: AmerisourceBergen is a member of the MediLedger working group.Our experience working with partners upstream and downstream provides MediLedger with the insights to create solutions that enable collaboration and adoption among stakeholders, two critical requirements to ensure the successful use of blockchain technology for DSCSA compliance.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report